Connect with us

News

Is The THC % Game Rigged?

Published

on

Is The THC % Game Rigged?

Go to almost any dispensary today and you will hear it: “This is 32%.” Budnenders Pitch Flower with a high thc high level, as if it is golden nuggets, consumers are in a hurry to grab banks with the highest number, and the plaster brands are like an honorary sign. In today’s market, the percentage of potentials are not just a selling point – they have become the entire cannabis personality.

But here’s the problem: the percent of Thc is one of the most deceptive and manipulated indicators in the field. Consumers believe that this is the highest quality measure, manufacturers feel pressure to multiply, except for numbers, and laboratories are under fire for inflating results. Truth is more ugly than most, and it rebuilds the cannabis future ways that can leave everyone worse.

Why do consumers pursue thc

Legalization led cannabis in the mainstream, but it also brought it to a mathematical problem: more thc = the best weed. For new consumers, especially those who are accustomed to the scale, the largest number on the bank feels like the safest rate. Why pay for a flower, indicated by 18% when 32% of the strain promises “almost twice as much as durability”?

Veterans know better. Anyone who has long been, knows that 17% deformation can knock you down, while 30% bud feels amazing. All because cannabis is not the only compound; This is a whole ecosystem, and each item works together to create balance and consequences. Cannabinoids, Terpens and flavonoids play together to create “high”. This is known as an entourage effect, and it often matters much more than the raw Thc content.

However, the customers of the dispensary strengthen the fixation. Many often refuse a spare flower when it tests below 25%, no matter how fragrant or unique. Manufacturers know this, and many admit that they feel the numbers to stay on the shelves.

Read the rest of this article about High Times, Click here

Message Or falsified the game thc %? appeared first further Retail Marijuana Retail Report – News and Information for Cannabis sellers.

(Tagstotranslate) Thc

Federal

Anti-Rescheduling Parties Ask Court To Stay Schedule III Cannabis Order

Published

on

By

Anti-Rescheduling Parties Ask Court To Stay Schedule III Cannabis Order

A national organization that promotes drug-free workplaces and a pharmaceutical company that specializes in cannabinoids filed a petition in federal court on June 9 to try to stop the Trump administration’s immediate devolution of medical cannabis.

The National Drug and Alcohol Administration Association (NDASA) and MMJ International Holdings, whose subsidiary has an active DEA Schedule I analytical laboratory registration, asked the U.S. Court of Appeals for the District of Columbia Circuit on April 22 to stop U.S. Attorney General Todd Blanche from acting. signed an order reclassifying the state license for medical cannabis to Schedule III until the court case to set aside the entire order is decided.

The plaintiffs argue that the court must consider four factors:

  1. A lawsuit between the human rights group NORML and the Drug Enforcement Administration (DEA) nearly 50 years ago;
  2. The transfer order “illegally” bypassed regulatory notice and comment;
  3. Two plaintiffs will “suffer irreparable harm” without a stay; and
  4. The balance of equity and public interest.

To read the rest of this article on Cannabis Business Times, Click here

Post Parties opposing deadline ask court to delay Schedule III cannabis order first appeared on Marijuana Retail Report – News and information for cannabis retailers.

Continue Reading

News

Marijuana Retail Report

Published

on

By

Marijuana Retail Report



Trulieve has completed a corporate restructuring

Trulieve Cannabis Corp. was the first An American cannabis company has received approval to list on a major US stock exchange.

The voting subsidiary of the Tallahassee, Florida-based company is expected to begin trading on the New York Stock Exchange on Wednesday under the ticker TRLV, the company said in a statement on Friday.

“As the first US cannabis company to go public on a major US exchange, we are excited about the opportunity to expand our shareholder base, increase liquidity and increase awareness of the benefits of medical marijuana,” said Trulieve Founder and CEO Kim Rivers.

“The move to the NYSE is an important development for Trulieve and the industry.”

To read the rest of this article on MJ Biz Daily, Click here

Continue Reading

AB 2697

Marijuana Retail Report

Published

on

By

Marijuana Retail Report



Under AB 2697, businesses would need approval from local jurisdictions

The California Senate Committee approved and passed the Assembly bill that would allow marijuana retailers to offer drive-through windows serve customers.

The measure, which passed the Senate Business, Professions and Economic Development Committee on a 7-3 vote Monday, says licensed cannabis retailers and micro-businesses with storefronts can sell marijuana products “to a customer in a vehicle in a drive-thru located on the premises.”

Under AB 2697 by Assemblywoman Gail Pellerin (D), businesses that sell cannabis would need approval from the local jurisdictions in which they operate to add a drive-thru option.

To read the rest of this article on marijuana moment, Click here

Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media